April 30, 2025Open Access

Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users

Key Points

Key points are not available for this paper at this time.

Abstract

Patients treated with SGLT2i had a small but significantly higher risk of postoperative eKA but lower risks of postoperative AKI and 30-day mortality.

KI fragen

Bookmark

View Full Paper

Cite This Study

Tallarico et al. (Wed,) studied this question.

synapsesocial.com/papers/69dd59480a7b4bc8c41017c6 https://doi.org/https://doi.org/10.1001/jamasurg.2025.0940

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Role of Remote Organs Effect in Acute Kidney Injury Outcome2017 · 32 citations
2Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future2022 · 28 citations
3The effect of preoperative sodium-glucose cotransporter 2 inhibitors on the incidence of perioperative metabolic acidosis: A retrospective cohort study2022 · 19 citations
4Metabolic Acidosis in Postsurgical Patient on Canagliflozin and Metformin: A Case Report2018 · 6 citations
5American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis2016 · 357 citations

KI fragen

Bookmark

View Full Paper